Goldman Sachs
SURF

Goldman Sachs’s Surface Oncology, Inc. Common Stock SURF Stock Holding History

Goldman Sachs’s Portfolio SURF Stock Details SURF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-633,569
Closed -$443K – 6199
2023
Q1 		$443K Sell
633,569
-450,898
-42% -$365K ﹤0.01% 4890
2022
Q4 		$889K Sell
1,084,467
-183,780
-14% -$181K ﹤0.01% 4495
2022
Q3 		$1.32M Buy
1,268,247
+198,336
+19% +$317K ﹤0.01% 4329
2022
Q2 		$1.75M Buy
1,069,911
+215,312
+25% +$447K ﹤0.01% 4152
2022
Q1 		$2.51M Buy
854,599
+140,980
+20% +$494K ﹤0.01% 4039
2021
Q4 		$3.41M Sell
713,619
-486,270
-41% -$3.14M ﹤0.01% 3775
2021
Q3 		$9.08M Buy
1,199,889
+432,647
+56% +$2.77M ﹤0.01% 2823
2021
Q2 		$5.72M Buy
767,242
+253,159
+49% +$1.95M ﹤0.01% 3211
2021
Q1 		$4.01M Buy
514,083
+494,073
+2,469% +$4.94M ﹤0.01% 3337
2020
Q4 		$185K Buy
20,010
+5,386
+37% +$46.8K ﹤0.01% 5118
2020
Q3 		$101K Sell
14,624
-11,824
-45% -$71.7K ﹤0.01% 5090
2020
Q2 		$173K Buy
26,448
+15,091
+133% +$54.5K ﹤0.01% 4847
2020
Q1 		$21K Sell
11,357
-8,817
-44% -$23.2K ﹤0.01% 5130
2019
Q4 		$38K Sell
20,174
-10,634
-35% -$17.7K ﹤0.01% 5140
2019
Q3 		$44K Sell
30,808
-17,939
-37% -$39.2K ﹤0.01% 5058
2019
Q2 		$137K Sell
48,747
-16,586
-25% -$66K ﹤0.01% 4878
2019
Q1 		$312K Buy
65,333
+23,517
+56% +$116K ﹤0.01% 4615
2018
Q4 		$177K Buy
41,816
+13,947
+50% +$108K ﹤0.01% 4863
2018
Q3 		$305K Sell
27,869
-30,399
-52% -$356K ﹤0.01% 4706
2018
Q2 		$950K Buy
+58,268
New +$843K ﹤0.01% 4112

Other funds holding SURF

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
AVAI
Atlas Venture Associates IX Boston, Massachusetts $11.8M AUM 58.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
YCM
Yakira Capital Management Westport, Connecticut $351M AUM 21.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Goldman Sachs's SURF Position: Q2 2023 in Review

Goldman Sachs sold out of Surface Oncology, Inc. Common Stock (SURF) in Q2 2023, closing a stake of 633,569 shares — an estimated $443K sold.

Goldman Sachs first reported a position in SURF in Q2 2018 and held it in 20 quarters. The position peaked at $9.08M in Q3 2021. 61 funds tracked by Wall St. Rank hold SURF as of Q2 2023.

  • Goldman Sachs reported no remaining Surface Oncology, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Goldman Sachs sold 633,569 Surface Oncology, Inc. Common Stock shares in Q2 2023, an estimated $443K.
  • Goldman Sachs first reported a position in Surface Oncology, Inc. Common Stock in Q2 2018 and held it in 20 quarters.
  • Goldman Sachs's Surface Oncology, Inc. Common Stock position peaked at $9.08M in Q3 2021.
  • 61 funds tracked by Wall St. Rank held Surface Oncology, Inc. Common Stock as of Q2 2023.

Based on Goldman Sachs's 13F filing for Q2 2023, filed 15 Aug 2023.